Insights

Expanding R&D Focus Orion Pharma's core research in oncology and pain management presents opportunities to introduce new therapeutic products or collaborate on innovative drug development initiatives that align with their strategic focus areas.

Digital Therapeutics Adoption The company's recent licensing agreement with Newel Health for a digital app targeting chronic pain indicates an openness to digital health solutions, suggesting potential for partnerships in digital therapeutics and telehealth services.

Collaborative Research Trends Ongoing partnerships with biotech firms like Evariste and Quantori highlight Orion Pharma's interest in advanced drug design and data-driven research, opening avenues for joint ventures in cutting-edge pharmaceutical technologies.

Global Market Presence With approximately 3,700 employees worldwide and revenue exceeding one billion euros, Orion Pharma's extensive international footprint offers sizable markets for product expansion, especially in oncology and neurological treatment segments.

Technological Integration Utilizing advanced tech stacks such as Oracle Cloud and PyTorch indicates their focus on leveraging data analytics and AI, which can be advantageous for sales of digital health platforms, analytical tools, and AI-powered solutions in pharmaceutical manufacturing and R&D.

Similar companies to Orion Pharma

Orion Pharma Tech Stack

Orion Pharma uses 8 technology products and services including Oracle Cloud, Emotion, jQuery, and more. Explore Orion Pharma's tech stack below.

Oracle Cloud
Data Management Platforms
Emotion
Javascript Frameworks
jQuery
Javascript Libraries
Swiper
Javascript Libraries
PyTorch
Machine Learning
Linux
Programming Languages
YouTube
Video Players
Google Analytics
Web Analytics

Media & News

Orion Pharma's Email Address Formats

Orion Pharma uses at least 1 format(s):

Orion Pharma Email Formats	Example	Percentage
First.Last@orion.fi	John.Doe@orion.fi	97%
Last.First@orion.fi	Doe.John@orion.fi	2%
FirstL@orion.fi	JohnD@orion.fi	1%

Frequently Asked Questions

Where is Orion Pharma's headquarters located?

Orion Pharma's main headquarters is located at Orionintie 1A, Espoo, FI-02101, FI. The company has employees across 6 continents, including EuropeAsiaNorth America.

What is Orion Pharma's phone number?

You can contact Orion Pharma's main corporate office by phone at

+1-262-377-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Orion Pharma's stock symbol?

Orion Pharma is a publicly traded company; the company's stock symbol is ONL.

What is Orion Pharma's official website and social media links?

Orion Pharma's official website is orion.fi and has social profiles on LinkedIn.

How much revenue does Orion Pharma generate?

As of October 2025, Orion Pharma's annual revenue is estimated to be $5B.

What is Orion Pharma's NAICS code?

Orion Pharma's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Orion Pharma have currently?

As of October 2025, Orion Pharma has approximately 3.1K employees across 6 continents, including EuropeAsiaNorth America. Key team members include Chief Commercial Officer & Us Country Head, Innovative Medicines: G. J.Chief Medical Officer, Head Of Global Medical Affairs: P. R.Chief Information Security Officer: U. P.. Explore Orion Pharma's employee directory with LeadIQ.

What industry does Orion Pharma belong to?

Orion Pharma operates in the Pharmaceutical Manufacturing industry.

What technology does Orion Pharma use?

Orion Pharma's tech stack includes Oracle CloudEmotionjQuerySwiperPyTorchLinuxYouTubeGoogle Analytics.

What is Orion Pharma's email format?

Orion Pharma's email format typically follows the pattern of First.Last@orion.fi. Find more Orion Pharma email formats with LeadIQ.

Orion Pharma

Pharmaceutical ManufacturingFinland1001-5000 Employees

Orion Corporation is a globally operating Nordic pharmaceutical company – a builder of well-being for over a hundred years. 

We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Orion Corporation has an extensive portfolio of proprietary and generic medicines and consumer health products. The core therapy areas of our pharmaceutical R&D are oncology and pain. Proprietary products developed by Orion Corporation are used to treat cancer, neurological diseases and respiratory diseases, among others. 

In 2024 Orion Group's net sales amounted to EUR 1,542 million and the company employed about 3,700 professionals worldwide, dedicated to building well-being. Orion Group's A and B shares are listed on Nasdaq Helsinki.

Product related questions and feedback: https://www.orionpharma.com/feedback